-
Featured Press Release
During Ovarian Cancer Awareness Month, Aspira Women's Health highlights its innovative mission and leadership
Learn More -
Featured Presentation
Aspira Women's Health, Inc. to Host Key Opinion Leader call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives
Watch Here
Recent News
-
Aspira Women’s Health Inc. Announces it is now an Anthem BlueCross BlueShield of Georgia Participating Provider
Over 173M lives covered with the addition of Anthem BlueCross BlueShield of Georgia, which covers approximately 3.3 million members across the state For a pdf copy of this release please click here AUSTIN, Texas — October 14, 2020 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it has…
-
Aspira Women’s Health, Inc. to Present at MicroCap Rodeo Best Ideas Bowl October 13-16
AUSTIN, Texas — October 9, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th – 16th, 2020. Aspira Women’s Health is scheduled to present on Wednesday, October…
-
Aspira Women’s Health has Emerged as a Global Leader for Innovations in Ovarian CancerRisk Assessment Starting with OVA1®plus, OVANex™, OVAInherit™, and ASPiRA GenetiX℠
During Ovarian Cancer Awareness Month, Aspira Women’s Health highlights its innovative mission and leadership in ovarian cancer detection and risk assessment using protein and genetics solutions Austin, Texas | September 28, 2020 For a pdf of this press release please click here September is Ovarian Cancer Awareness Month. Ovarian cancer is the deadliest gynecologic cancer¹,…
-
Aspira Women’s Health, Inc. to Host Key Opinion Leader Call on Ovarian Cancer Diagnostics, Innovation Pipeline, and Rebranding Initiatives
For a pdf of this press release please click here AUSTIN, Texas — September 15, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will host a key opinion leader (KOL) call on ovarian cancer diagnostics, innovation pipeline, and rebranding initiatives on Friday, September 25, 2020 at 12:00pm…
-
Aspira Women’s Health, Inc., to Present at Cantor Virtual Healthcare Conference
For a pdf of this press release please click here AUSTIN, Texas — September 8, 2020 — Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the 2020 Cantor Virtual Healthcare Conference taking place on September 15-17, 2020. Valerie Palmieri, President and Chief Executive Officer, and Robert…